HOLLAND & KNIGHT LLP

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 2

Budget/Appropriations

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Health Issues

H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.